GlobeNewswire by notified

Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)

Share

SAMPO PLC                        STOCK EXCHANGE RELEASE                                        6 September 2022 at 9:00

Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)

Sampo plc (business code 0142213-3) has received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the total number of voting rights attached to Sampo A shares (ISIN: FI009003305) owned directly, indirectly or through financial instruments by BlackRock, Inc. (USA tax ID 32-0174421) and its funds increased on 2 September 2022 above five (5) per cent of Sampo plc’s total voting rights. In addition, the disclosure obligation arose due to the A shares and voting rights owned directly or indirectly by BlackRock, Inc. and its funds increasing above five (5) per cent of all Sampo plc’s shares and voting rights.

Sampo's share capital comprises 533,261,351 shares, of which 533,061,351 are A shares and 200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 534,061,351.

Total positions of BlackRock, Inc and its funds subject to the notification:

% of shares and voting rights (total of A)% of shares and voting rights through financial instruments (total of B)Total of both in % (A+B)
Resulting situation on the date on which threshold was crossed or reached5.02% shares

5.01% voting rights
0.05% shares

0.05% voting rights
5.08% shares

5.07% voting rights
Positions of previous notification (if applicable)4.94% shares

Below 5% voting rights
0.05% shares

Below 5% voting rights
5.00% shares

Below 5% voting rights

Notified details of the resulting situation on the date on which the threshold was crossed:

A: Shares and voting rights:

Class/type of shares
ISIN code
Number of shares and voting rights% of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
FI000900330526,809,861 shares

26,809,861 voting rights
5.02% shares

5.01% voting rights
SUBTOTAL A26,809,861 shares

26,809,861 voting rights
5.02% shares

5.01% voting rights

B: Financial instruments according to SMA 9:6a:

Type of financial
instrument
Expiration dateExercise/
Conversion Period
Physical or
cash settlement
Number of shares
and voting rights
% of shares and
voting rights
American Depository Receipt (US79588J1025)N/AN/APhysical258,554 shares

258,554 voting rights
0.04% shares

0.04% voting rights
Securities LentN/AN/APhysical4,194 shares

4,194 voting rights
0.00% shares

0.00% voting rights
CFDN/AN/ACash35,282 shares

35,282 voting rights
0.00% shares

0.00% voting rights
SUBTOTAL B298,030 shares

298,030 voting rights
0.05% shares

0.05% voting rights

SAMPO PLC

Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030

Distribution:
Nasdaq Helsinki
London stock exchange
The principal media
Financial Supervisory Authority
www.sampo.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Havila Kystruten AS: Havila Pollux Cancels Upcoming Round Trip8.5.2024 23:15:38 CEST | Press release

Havila Pollux has been docked in Bergen since May 2nd for planned warranty work, after an electro motor supplying power to the propulsion system had to be replaced. In recent days, testing of the new electro motor has been conducted, during which a malfunction was discovered in a bearing in the underwater housing of one of the propellers (azimuth POD). Sailing the ship in service with this malfunction is not deemed safe, and the newly discovered issue must be rectified. Consequently, Havila Pollux will sail to GMC in Stavanger to be placed in dry-dock for the replacement of the propeller's underwater housing. This replacement is also considered warranty work. As a result, the upcoming round trip departing from Bergen on May 13th will be cancelled. Considering the necessary preparations by the Norwegian equipment supplier and the replacement of the underwater housing, it is expected that Havila Pollux will resume its regular service from Bergen no later than May 24th. All affected passe

Havila Kystruten AS: Havila Pollux kansellerer kommende rundtur8.5.2024 23:15:38 CEST | Pressemelding

Havila Pollux har siden 2. mai ligget til kai i Bergen for planlagte garantiarbeider, etter at en elektromotor som forsyner propellsystemet med kraft måtte byttes ut. De siste dagene har det vært utført testing av den nye elektromotoren, og i forbindelse med det er det oppdaget en feil på et lager i undervannshuset til den ene propellen (azimut POD). Å seile skipet i rute med denne feilen er ikke sikkerhetsmessig forsvarlig, og den nyoppdagede feilen må utbedres. Havila Pollux vil derfor seile til GMC i Stavanger for å settes i tørrdokk for bytte av undervannshuset til propellen. Denne utskiftingen anses også som garantiarbeid. Den kommende rundturen med avgang fra Bergen 13. mai vil derfor kanselleres. Hensyntatt nødvendige forberedelser fra den norske utstyrsleverandøren samt utskiftning av undervannshuset, er det er forventet at Havila Pollux er tilbake i rute igjen fra Bergen senest 24. mai. Alle berørte passasjerer blir kontaktet av Havila Kystruten. Kontakter: Administrerende dir

Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update8.5.2024 22:15:38 CEST | Press release

Petosemtamab in combination with pembrolizumab in 1L HNSCC initial interim clinical data at 2024 ASCO Annual Meeting; preparing for a potential phase 3 trial Zeno BLA accepted for priority review by the FDA for the treatment of NRG1+ NSCLC and PDACBased on the Company’s current operating plan, existing cash, cash equivalents and marketable securities expected to fund Merus’ operations into 2027 UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced financial results for the first quarter and provided a business update. “At the upcoming 2024 ASCO meeting, we are looking forward to presenting multiple datasets including the first clinical data on safety and efficacy of petosemtamab in combination with pembrolizumab in previously untreated head and neck cancer. With p

CrossAmerica Partners LP Reports First Quarter 2024 Results8.5.2024 22:15:00 CEST | Press release

Allentown, PA, May 08, 2024 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Reports First Quarter 2024 Results Reported First Quarter 2024 Net Loss of $17.5 million that includes a $15.9 million loss on lease terminations with Applegreen, Adjusted EBITDA of $23.6 million and Distributable Cash Flow of $11.7 million compared to a Net Loss of $1.0 million, Adjusted EBITDA of $31.7 million and Distributable Cash Flow of $19.1 million for the First Quarter 2023Reported First Quarter 2024 Gross Profit for the Wholesale Segment of $27.0 million compared to $31.2 million of Gross Profit for the First Quarter 2023 and First Quarter 2024 Gross Profit for the Retail Segment of $54.4 million compared to $50.8 million of Gross Profit for the First Quarter 2023Leverage, as defined in the CAPL Credit Facility, was 4.49 times as of March 31, 2024, compared to 4.21 times as of December 31, 2023The Distribution Coverage Ratio for the trailing twelve months ended March 31, 2024 was 1.37 times compared to 1

HiddenA line styled icon from Orion Icon Library.Eye